A Critical time for practice change in the pain treatment continuum: We need to reconsider the role of pumps in the patient care algorithm

Pain Medicine

Volumn 11, Issue 7, 2010, Pages 987-989

  Deer, Timothy R ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; OPIATE; ANALGESIC AGENT;

ALGORITHM; CANCER PAIN; CHRONIC PAIN; DRUG DELIVERY SYSTEM; DRUG SAFETY; EDITORIAL; HUMAN; INFUSION PUMP; MEDICAL DECISION MAKING; NERVE STIMULATION; PATIENT CARE; QUALITY OF LIFE; SPINAL CORD STIMULATION; DECISION MAKING; PAIN; PRACTICE GUIDELINE; TIME; UTILIZATION;

ALGORITHMS; ANALGESICS; DECISION MAKING; GUIDELINES AS TOPIC; HUMANS; INFUSION PUMPS, IMPLANTABLE; PAIN; PATIENT CARE; TIME FACTORS;

EID: 77955135907     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00886.x     Document Type: Editorial

References (15)

1. Coffey R, Broste S, DuBois M. Medical practice perspective: Identification and mitigation of risk factors for mortality associated with intrathecal opioids for non-cancer pain. Pain Med 2010, 11(7):1001-9.
2. Deer T, Winkelmuller W, Erdine S, Bedder M, Burchiel K. Intrathecal therapy for cancer and nonmalignant pain: Patient selection and patient management. Neuromodulation 2002, 2(2):55-66.
3. Deer T, Chapple I, Classen A. Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain. Pain Med 2004, 5(1):6-13.
4. Krames E. Intrathecal infusional therapies for intractable pain: Patient management guidelines. J Pain Symptom Manage 1993, 8(7):451-3.
5. Smith T, Staats P, Deer T. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, survival. J Clin Oncol 2002, 20(19):4040-9.
6. Bennett G, Serafini M, Burchiel K. Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 2000, 20:S12-36.
7. Hassenbusch SJ, Portenoy RK, Cousins M. Polyanalgesic consensus conference 2003: An update on the management of pain by intraspinal drug delivery-Report of an expert panel. J Pain Symptom Manage 2004, 27(6):540-63.
8. Deer T, Krames E, Hassenbusch S. Polyanalgesic consensus conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007, 10(4):300-28.
9. Krames E, Poree L, Deer T, Levy R. Implementing the SAFE principles for the development of pain medicine therapeutic algorithms that include neuromodulation techniques. Neuromodulation 2009, 12(2):104-13.
10. Krames E, Poree L, Deer T, Levy R. Rethinking algorithms of pain care: The use of the S.A.F.E. principles. Pain Med 2009, 10(1):1-5.
11. Turner J, Sear J, Loeser J. Programmable intrathecal opioid delivery systems for chronic noncancer pain: A systematic review of effectiveness and complications. Clin J Pain 2007, 23(2):180-95.
12. Coffey RJ, Owens ML, Broste SK. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat non-cancer pain. Anesthesiology 2009, 111(4):881-91.
13. Rathmell JP, Matthew MJ. Death after initiation of intrathecal drug therapy for chronic pain. Anesthesiology 2009, 111(4):706-8.
14. Deer T, Smith H, Doleys D. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician Accepted for Publication, February 2010
15. Deer T, Krames E, Hassenbusch S. Management of intrathecal catheter-tip inflammatory masses: An updated 2007 consensus statement from an expert panel. Neuromodulation 2008, 11(2):77-91.